These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 470509)

  • 1. [Extraskeletal manifestations of unusual localization in a case of myeloma (author's transl)].
    Sanz MA; Mayans J; Martínez J; Caballero O; Marty ML
    Med Clin (Barc); 1979 Jul; 73(3):118-21. PubMed ID: 470509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sideroblastic anemia in a multiple myeloma treated by melphalan (author's transl)].
    Phelip X; Grosclaude S; Rouge P; Mouries D; Blanc D
    Sem Hop; 1979 Oct 18-25; 55(35-36):1633-5. PubMed ID: 231836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extraskeletal diffusion of multiple myeloma. A clinico-pathological description of 4 cases].
    Cantore M; Smerieri F; Bucalossi A; Leoncini L
    Recenti Prog Med; 1991 Nov; 82(11):598-602. PubMed ID: 1763233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Smoldering myeloma].
    Dolgos J; Patakfalvi A
    Orv Hetil; 1993 Sep; 134(39):2155-7. PubMed ID: 8414460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic problems raised by tumors of the skull. A propos 2 cases (author's transl)].
    Mendes da Costa P; Jortay A; Noterman J
    Acta Chir Belg; 1974 Sep; 73(5):554-62. PubMed ID: 4440369
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy results and clinical course in 91 cases of multiple myeloma with regard to their clinical staging (author's transl)].
    Rubio Felix D; Giraldo MP; Raichs A; García Zueco JC; Mur P; Faura MV; Ruíz-Marcuello E; Piñan MA
    Sangre (Barc); 1980; 25(1):25-34. PubMed ID: 7384962
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
    Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Nunzi M; Grasso M; Falco P; Cangialosi C; Boccadoro M
    Cancer; 2005 Oct; 104(7):1428-33. PubMed ID: 16116606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2 cases of multiple myeloma with osteosclerosis].
    Felder M; Keiser G; Wirth W
    Schweiz Med Wochenschr; 1979 Nov; 109(44):1713-9. PubMed ID: 524105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of systemic manifestations of cryoglobulinemia. Treatment with melphalan and prednisone.
    Ristow SC; Griner PF; Abraham GN; Shoulson I
    Arch Intern Med; 1976 Apr; 136(4):467-70. PubMed ID: 1267555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission maintenance therapy for multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biclonal myeloma (IgG and IgA)].
    González Barón M; Martínez Fernández A; Durán A; Montero JM; Ordoñez A; Gasalla R
    Rev Clin Esp; 1973 Feb; 128(4):345-8. PubMed ID: 4700587
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple myeloma transforming into acute leukaemia (author's transl)].
    Mayans J; Redon J; Badia L; Herranz C; Calabuig JR; Sanz MA; Soler A; Caballero M; Marty ML
    Sangre (Barc); 1977; 22(6):1026-9. PubMed ID: 601670
    [No Abstract]   [Full Text] [Related]  

  • 13. Results and further perspectives of plasmocytoma chemotherapy.
    Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J
    Neoplasma; 1986; 33(2):251-8. PubMed ID: 3520353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and laboratory analysis of the cases of multiple myeloma with over 5-year survival time from the beginning of the antineoplastic treatment].
    Kraj M; Rostkowska J; Sokołowska U; Maj S
    Acta Haematol Pol; 1991; 22(1):42-7. PubMed ID: 1823966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the results of treatment of multiple myeloma].
    Snigurowicz J; Rostkowska J; Kraj M; Mariańska B
    Acta Haematol Pol; 1979 Oct; 10(4):227-35. PubMed ID: 539350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma first observed as multiple cutaneous plasmacytomas.
    Shah A; Klimo P; Worth A
    Arch Dermatol; 1982 Nov; 118(11):922-4. PubMed ID: 6814367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.
    Palumbo A; Falco P; Corradini P; Falcone A; Di Raimondo F; Giuliani N; Crippa C; Ciccone G; Omedè P; Ambrosini MT; Gay F; Bringhen S; Musto P; Foà R; Knight R; Zeldis JB; Boccadoro M; Petrucci MT;
    J Clin Oncol; 2007 Oct; 25(28):4459-65. PubMed ID: 17785703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of malignant skeletal tumors (author's transl)].
    Brunner KW; Wagner HP
    Ther Umsch; 1979 Jul; 36(7):653-6. PubMed ID: 89708
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors and survival in multiple myeloma. Analysis of 91 cases treated by melphalan and prednisone.
    Gobbi M; Cavo M; Savelli G; Baccarani M; Tura S
    Haematologica; 1980 Aug; 65(4):437-45. PubMed ID: 6774915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case].
    Scolozzi R; Boccafogli A
    Minerva Med; 1983 Jul; 74(28-29):1783-5. PubMed ID: 6866310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.